BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Sun W, Zhou X, Gong H, Chen Y, Chen D, Xiang F. Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-κB Signaling Pathways. Biomed Res Int 2019;2019:1415809. [PMID: 31781591 DOI: 10.1155/2019/1415809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen M, Ding Y, Tong Z. Efficacy and Safety of Sophora flavescens (Kushen) Based Traditional Chinese Medicine in the Treatment of Ulcerative Colitis: Clinical Evidence and Potential Mechanisms. Front Pharmacol 2020;11:603476. [PMID: 33362558 DOI: 10.3389/fphar.2020.603476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
2 Xia S, Wang Z, Chen L, Zhou Y, Li Y, Wang S, Chen A, Xu X, Shao J, Zhang Z, Tan S, Zhang F, Zheng S. Dihydroartemisinin regulates lipid droplet metabolism in hepatic stellate cells by inhibiting lncRNA-H19-induced AMPK signal. Biochem Pharmacol 2021;192:114730. [PMID: 34400125 DOI: 10.1016/j.bcp.2021.114730] [Reference Citation Analysis]
3 Wang CZ, Wan C, Luo Y, Zhang CF, Zhang QH, Chen L, Liu Z, Wang DH, Lager M, Li CH, Jiang TL, Hou L, Yuan CS. Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation. Mol Biol Rep 2022. [PMID: 35040004 DOI: 10.1007/s11033-021-07079-1] [Reference Citation Analysis]
4 Liang R, Chen W, Fan H, Chen X, Zhang J, Zhu JS. Dihydroartemisinin prevents dextran sodium sulphate-induced colitisthrough inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling. Int Immunopharmacol 2020;88:106949. [PMID: 32892075 DOI: 10.1016/j.intimp.2020.106949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Qiu F, Liu J, Mo X, Liu H, Chen Y, Dai Z. Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs. Front Immunol 2021;12:751772. [PMID: 34567013 DOI: 10.3389/fimmu.2021.751772] [Reference Citation Analysis]
6 Yang S, Wang X, Xiao W, Xu Z, Ye H, Sha X, Yang H. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts. Front Endocrinol 2022;13:891922. [DOI: 10.3389/fendo.2022.891922] [Reference Citation Analysis]
7 Yu R, Jin G, Fujimoto M. Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases. Front Oncol 2021;11:722331. [PMID: 34692496 DOI: 10.3389/fonc.2021.722331] [Reference Citation Analysis]
8 Shi G, Jiang H, Feng J, Zheng X, Zhang D, Jiang C, Zhang J. Aloe vera mitigates dextran sulfate sodium-induced rat ulcerative colitis by potentiating colon mucus barrier. J Ethnopharmacol 2021;279:114108. [PMID: 33839199 DOI: 10.1016/j.jep.2021.114108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Bai B, Wu F, Ying K, Xu Y, Shan L, Lv Y, Gao X, Xu D, Lu J, Xie B. Therapeutic effects of dihydroartemisinin in multiple stages of colitis-associated colorectal cancer. Theranostics 2021;11:6225-39. [PMID: 33995655 DOI: 10.7150/thno.55939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Fan L, Zhang Y, Chen Y, Chen L, Xu W, Nan L, Xu W, Lu B, Wang Y, Chu K, Zhang J. Cryptotanshinone ameliorates dextran sulfate sodium-induced murine acute and chronic ulcerative colitis via suppressing STAT3 activation and Th17 cell differentiation. International Immunopharmacology 2022;108:108894. [DOI: 10.1016/j.intimp.2022.108894] [Reference Citation Analysis]
11 Saito Y, Shimizu M, Iwatsuki K, Hanyu H, Tadaishi M, Sugita-Konishi Y, Kobayashi-Hattori K. Effect of short-time treatment with TNF-α on stem cell activity and barrier function in enteroids. Cytotechnology 2021;73:669-82. [PMID: 34349355 DOI: 10.1007/s10616-021-00487-y] [Reference Citation Analysis]
12 Feng H, Wu T, Zhou Q, Li H, Liu T, Ma X, Yue R, Hassan I. Protective Effect and Possible Mechanisms of Artemisinin and Its Derivatives for Diabetic Nephropathy: A Systematic Review and Meta-Analysis in Animal Models. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/5401760] [Reference Citation Analysis]
13 Lee H, Son YS, Lee MO, Ryu JW, Park K, Kwon O, Jung KB, Kim K, Ryu TY, Baek A, Kim J, Jung CR, Ryu CM, Park YJ, Han TS, Kim DS, Cho HS, Son MY. Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways. Theranostics 2020;10:5048-63. [PMID: 32308767 DOI: 10.7150/thno.41534] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
14 Fouad MR, Salama RM, Zaki HF, El-Sahar AE. Vildagliptin attenuates acetic acid-induced colitis in rats via targeting PI3K/Akt/NFκB, Nrf2 and CREB signaling pathways and the expression of lncRNA IFNG-AS1 and miR-146a. Int Immunopharmacol 2021;92:107354. [PMID: 33434756 DOI: 10.1016/j.intimp.2020.107354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rana MN, Lu J, Xue E, Ruan J, Liu Y, Zhang L, Dhar R, Li Y, Hu Z, Zhou J, Ma W, Tang H. PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization. Front Pharmacol 2021;12:643215. [PMID: 33967779 DOI: 10.3389/fphar.2021.643215] [Reference Citation Analysis]
16 Guan S, Jin T, Han S, Fan W, Chu H, Liang Y. Dihydroartemisinin alleviates morphine-induced neuroinflammation in BV-2 cells. Bioengineered 2021;12:9401-10. [PMID: 34854364 DOI: 10.1080/21655979.2021.1982311] [Reference Citation Analysis]
17 Yang B, Gao X, Sun Y, Zhao J, Chen J, Gao L, Zhao L, Li Y. Dihydroartemisinin alleviates high glucose-induced vascular smooth muscle cells proliferation and inflammation by depressing the miR-376b-3p/KLF15 pathway. Biochem Biophys Res Commun 2020;530:574-80. [PMID: 32753318 DOI: 10.1016/j.bbrc.2020.07.095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]